Related Experiment Video
Updated: May 25, 2025

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
The epigenetic landscape of brain metastasis
Aoibhín M Powell1, Louise Watson2, Lara Luzietti1
1School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Abstract:
Brain metastasis represents a significant challenge in oncology, driven by complex molecular and epigenetic mechanisms that distinguish it from primary tumors. While recent research has focused on identifying genomic mutation drivers with potential clinical utility, these strategies have not pinpointed specific genetic mutations responsible for site-specific metastasis to the brain. It is now clear that successful brain colonization by metastatic cancer cells requires intricate interactions with the brain tumor ecosystem and the acquisition of specialized molecular traits that facilitate their adaptation to this highly selective environment. This is best exemplified by widespread transcriptional adaptation during brain metastasis, resulting in aberrant gene programs that promote extravasation, seeding, and colonization of the brain. Increasing evidence suggests that epigenetic mechanisms play a significant role in shaping these pro-brain metastasis traits. This review explores dysregulated chromatin patterns driven by chromatin remodeling, histone modifications, DNA/RNA methylation, and other epigenetic regulators that underpin brain metastatic seeding, initiation, and outgrowth. We provide novel insights into how these epigenetic modifications arise within both the brain metastatic tumor and the surrounding brain metastatic tumor ecosystem. Finally, we discuss how the inherent plasticity and reversibility of the epigenomic landscape in brain metastases may offer new therapeutic opportunities.
Insights
Brain metastasis is a complex challenge. Epigenetic changes, not just gene mutations, drive cancer cells to adapt and colonize the brain, offering new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Brain metastasis poses a significant challenge in cancer treatment.
- Genomic mutations alone do not fully explain site-specific brain metastasis.
- Cancer cell adaptation to the brain microenvironment is crucial for colonization.
Purpose of the Study:
- To review the role of epigenetic mechanisms in brain metastasis.
- To explore how epigenetic dysregulation facilitates brain colonization.
- To discuss therapeutic opportunities arising from the epigenomic landscape of brain metastases.
Main Methods:
- Review of current literature on brain metastasis and epigenetics.
- Analysis of transcriptional adaptations and gene programs in brain metastatic cells.
- Investigation of chromatin remodeling, histone modifications, and DNA/RNA methylation in brain metastases.
Main Results:
- Epigenetic mechanisms, including chromatin remodeling and methylation, are critical for brain metastasis.
- Aberrant gene programs promote cancer cell extravasation, seeding, and colonization in the brain.
- Epigenetic modifications occur in both metastatic cells and the brain tumor ecosystem.
Conclusions:
- Epigenetic dysregulation plays a pivotal role in the development of brain metastases.
- The plasticity of the epigenome in brain metastases presents potential therapeutic avenues.
- Targeting epigenetic mechanisms could offer novel treatment strategies for brain metastasis.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment

